Gordon E. Nye
Vorstandsvorsitzender bei Clear Intradermal Technologies, Inc.
Profil
Gordon E.
Nye currently works at R2 Dermatology, Inc., as Chief Executive Officer, Clear Intradermal Technologies, Inc., as Chief Executive Officer & Director, and Group Outcome LLC, as Managing Director.
Mr. Nye also formerly worked at ZELTIQ Aesthetics, Inc., as President, Chief Executive Officer & Director from 2009 to 2012, Critikon Co. LLC, as Chief Executive Officer in 2003, Avertix Medical Systems, Inc., as Chief Executive Officer from 2020 to 2021, A Co. Orthodontics, Inc., as Chief Executive Officer in 2003, ROX Medical, Inc., as Director, CoAxia, Inc., as Director, Myocor, Inc., as Director, IScience Surgical Corp., as Director, Aptus Endosystems, Inc., as Director, Insulet Corp., as Director in 2008, REVA Medical, Inc., as Independent Non-Executive Director from 1999 to 2017, Confirma, Inc., as Director, Systagenix Wound Management Ltd., as Director, and Prism Venture Management LLC, as Principal from 2003 to 2009.
Mr. Nye received his undergraduate degree and Masters Business Admin degree from Tuck School of Business at Dartmouth.
Aktive Positionen von Gordon E. Nye
| Unternehmen | Position | Beginn |
|---|---|---|
Group Outcome LLC
 Group Outcome LLC Investment Banks/BrokersFinance Group Outcome LLC provides financial advisory services. The company was founded in April 1999 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 30.12.2010 |
| R2 Dermatology, Inc. | Vorstandsvorsitzender | - |
Clear Intradermal Technologies, Inc.
 Clear Intradermal Technologies, Inc. Medical SpecialtiesHealth Technology Clear Intradermal Technologies, Inc. has invented the Eraser™ system, which is an efficient, pain-free, and effective device that promises to transform the patient journey. The company is based in New York, NY. The company's team of proven, passionate innovators is committed to delivering their patented removal system to affordably, comfortably, and time-efficiently "clear" unwanted tattoos. The company was founded in 2003 by James W. Winkelman, Martin E. Schmieg. The CEO is Gordon E. Nye. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Gordon E. Nye
| Unternehmen | Position | Ende |
|---|---|---|
Avertix Medical Systems, Inc.
 Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Vorstandsvorsitzender | 22.06.2021 |
| REVA MEDICAL INC | Direktor/Vorstandsmitglied | 14.07.2017 |
| ZELTIQ AESTHETICS INC | Vorstandsvorsitzender | 18.04.2012 |
Prism Venture Management LLC
 Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Private Equity Investor | 31.12.2009 |
| INSULET CORPORATION | Direktor/Vorstandsmitglied | 01.01.2008 |
Ausbildung von Gordon E. Nye
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INSULET CORPORATION | Health Technology |
| Private Unternehmen | 16 |
|---|---|
ROX Medical, Inc.
 ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | Health Technology |
CoAxia, Inc.
 CoAxia, Inc. Medical/Nursing ServicesHealth Services CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD. | Health Services |
Myocor, Inc.
 Myocor, Inc. Medical SpecialtiesHealth Technology Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN. | Health Technology |
| IScience Surgical Corp. | Health Services |
Aptus Endosystems, Inc.
 Aptus Endosystems, Inc. Medical SpecialtiesHealth Technology Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Prism Venture Management LLC
Prism Venture Management LLC Investment ManagersFinance Prism Venture Management LLC (Prism Venture Management) is a venture capital firm founded in 1996 by Bob C. Fleming and John L. Brooks. The firm is headquartered in Needham, Massachusetts. | Finance |
Critikon Co. LLC
 Critikon Co. LLC Medical SpecialtiesHealth Technology Critikon Co. LLC provides blood pressure monitoring products and software for patient information systems. The company is headquartered in Tampa, FL. | Health Technology |
REVA Medical, Inc.
 REVA Medical, Inc. Medical SpecialtiesHealth Technology REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA. | Health Technology |
Confirma, Inc.
 Confirma, Inc. Packaged SoftwareTechnology Services Confirma, Inc. develops and markets computer aided detection systems and accessories for medical imaging. The firm's products include CADstream, CADalog, and SureLoc. The company was founded in 1998 and is headquartered in Bellevue, WA. | Technology Services |
Group Outcome LLC
Group Outcome LLC Investment Banks/BrokersFinance Group Outcome LLC provides financial advisory services. The company was founded in April 1999 and is headquartered in Princeton, NJ. | Finance |
Avertix Medical Systems, Inc.
Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Distribution Services |
Systagenix Wound Management Ltd.
 Systagenix Wound Management Ltd. Medical SpecialtiesHealth Technology Systagenix Wound Management Ltd. develops wound care products. It manufactures and supplies wound care products for healthcare professionals and patients worldwide. Its products portfolio includes non-adherent hydro-alginate antimicrobial dressings; sterile and non-woven pads; activated charcoal dressings; and wound balancing and protease modulating matrix products. The company was founded in 2008 and is headquartered in Gatwick, the United Kingdom. | Health Technology |
| A Co. Orthodontics, Inc. | |
| R2 Dermatology, Inc. | |
Clear Intradermal Technologies, Inc.
Clear Intradermal Technologies, Inc. Medical SpecialtiesHealth Technology Clear Intradermal Technologies, Inc. has invented the Eraser™ system, which is an efficient, pain-free, and effective device that promises to transform the patient journey. The company is based in New York, NY. The company's team of proven, passionate innovators is committed to delivering their patented removal system to affordably, comfortably, and time-efficiently "clear" unwanted tattoos. The company was founded in 2003 by James W. Winkelman, Martin E. Schmieg. The CEO is Gordon E. Nye. | Health Technology |
